Should surgery remain the initial treatment of “operable” breast cancer?-Reference-Cited by-同舟云学术

Should surgery remain the initial treatment of “operable” breast cancer?

Published:1991-12 Issue:12 Volume:27 Page:1539-1542
ISSN:0277-5379
Container-title:European Journal of Cancer and Clinical Oncology
language:en
Short-container-title:European Journal of Cancer and Clinical Oncology

Author:

Kurtz John M.

Publisher

Elsevier BV

Subject

Oncology

Reference20 articles.

1. Breast conservation is the treatment of choice in small breast cancers: long-term results of a randomised trial;Veronesi;Eur J Cancer,1990

2. Ten-year results of a randomised trial comparing a conservative treatment to mastectomy in early breast cancer;Sarrazin;Radiother Oncol,1989

3. Eight-year results of a randomized trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer;Fisher;N Engl J Med,1989

4. van Dongen JA, Bartelink H, Fentiman I, et al. Randomised clinical trial to assess the value of breast conserving therapy (BCT) in stage I and II breast cancer: EORTC Trial 10801. NCI Monographs (in press).

5. The effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer: an overview of 61 randomized trials among 28,896 women;N Engl J Med,1988

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Attitudes towards breast conservation in patients aged over 70 with breast cancer;SpringerPlus;2016-04-18

2. Neoadjuvant tamoxifen and aromatase inhibitors: comparisons and clinical outcomes;The Journal of Steroid Biochemistry and Molecular Biology;2003-09

3. Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study;Annals of Oncology;2001-11

4. Neoadjuvante Chemotherapie bei lokal fortgeschrittenen Mammakarzinomen: Tumorregression und perioperative Komplikationen;Geburtshilfe und Frauenheilkunde;1998-01

5. Does induction chemotherapy with a mitoxantrone/vinorelbine regimen allow a breast-conservative treatment in patients with operable locoregional breast cancer?;Breast Cancer Research and Treatment;1996-06